Miltiadis Paliouras, Ph.D. (Assistant Professor, Department of Medicine, McGill University), received his Ph.D. from McGill University in 2005 in field of developmental biology. He then proceed to do his post-doctoral studies at the Samuel Lunenfeld Research Institute at Mount Sinair Hospital-University of Toronto, studying the genetic regulation of human tissue kallikreins in neoplastic tissue. He followed this work with another post-doctoral fellowship at the Lady Davis Institute at the Jewish General Hospital-McGill University focusing on novel properties of the androgen receptor in prostate cancer.
In 2010 he received his academic appointment at McGill University, with research interests in exploring the molecular mechanisms accounting for cancer evolution and progression. As a result his work has also moved towards the development of novel cancer therapeutics and animal models for pre-clinical studies. He has published widely and presented his work at several domestic and international conferences. He brings to Pronto Medical Technologies Inc., a deep background and provides an exceptional resource in fields of genetics and molecular biological techniques, as well as strong managerial skills to ensure the success of the company.